Threshold Pharmaceuticals, Inc. (THLD) Announces Presentations and Webcasts at Three Upcoming Investor Conferences
5/10/2013 7:19:51 AM
More...
|
Threshold Pharmaceuticals, Inc. (THLD) Reports First Quarter 2013 Financial and Operational Results
5/2/2013 11:52:35 AM
More...
|
Threshold Pharmaceuticals, Inc. (THLD) Announces Presentation and Webcast at the 12th Annual Needham Healthcare Conference
4/25/2013 12:16:03 PM
More...
|
Threshold Pharmaceuticals, Inc. (THLD) Announces Presentation and Webcast at the 20th Annual Future Leaders in the Biotech Industry Conference
4/1/2013 8:55:51 AM
More...
|
Threshold Pharmaceuticals, Inc. (THLD) Announces Acquisition of Investigational Hypoxia PET Imaging Agent [18F]HX4 From Siemens Healthcare (SI)
3/21/2013 9:54:58 AM
More...
|
Threshold Pharmaceuticals, Inc. (THLD) Reports Fourth Quarter and Year End 2012 Financial and Operational Results
3/7/2013 9:45:46 AM
More...
|
Threshold Pharmaceuticals, Inc. (THLD) Announces Presentation and Webcast at Cowen and Company's 33rd Annual Health Care Conference
2/26/2013 9:22:54 AM
More...
|
Threshold Pharmaceuticals, Inc. (THLD) Higher as Phase 3 Moves Forward, Earns $30 Million Milestone Payment
1/25/2013 6:58:41 AM
More...
|
Threshold Pharmaceuticals, Inc. (THLD) Announces Presentation and Webcast at Oppenheimer 23rd Annual Healthcare Conference
12/10/2012 9:19:50 AM
More...
|
Threshold Pharmaceuticals, Inc. (THLD) Reports Updated Phase 2 Results Including Analysis of Maintenance Therapy With TH-302 Following Induction Therapy With TH-302 Plus Doxorubicin in Soft Tissue Sarcoma
11/15/2012 8:55:16 AM
More...
|
|